Portfolio company
Innovative brain-machine interfaces
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Merge Labs develops ultrasound-based, non-invasive brain-machine interfaces that link biological and artificial intelligence for individuals with neurological disorders and able-bodied users.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Synaptrix Labs
The company develops non-invasive brain-computer interfaces and AI models to provide mobility and communication control for patients with severe motor impairments.
Neuroharmonics
This company develops non-invasive ultrasound devices to modulate deep brain circuits for patients with movement disorders, depression, chronic pain, and addiction.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
Inner Cosmos
This company develops a minimally invasive brain-computer interface implant to treat cognitive disorders for patients suffering from depression.
Ultra Bionics
The company develops implantable ultrasound technologies to provide neuromodulation and neurological disease therapies for patients with conditions such as Parkinson's and epilepsy.
Infera Neuro
This company develops neural-decoding chips for brain-computer interfaces to restore communication for individuals with speech loss caused by stroke or neurodegenerative disease.
Precision Neuroscience
Precision Neuroscience develops minimally invasive brain-computer interfaces to help patients with paralysis and neurological disorders control digital devices using their thoughts.
